Atherosclerosis Drugs Market by Drug Type (Anti-platelet and Anticoagulants, Cholesterol Lowering Medication, ACE Inhibitors, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2023-2032

This section provides various opinions of the top-level CXOs in the atherosclerosis drugs industry. In accordance with several interviews conducted, the utilization of atherosclerosis drugs is expected to witness a significant rise owing to increase in prevalence of cardiovascular diseases and obesity in both developed and developing economies.???  

Furthermore, the global atherosclerosis drugs market growth is propelled by surge in geriatric population suffering from cardiovascular disorders, increase in adoption of an unhealthy diet, and lack of physical activities due to busy lifestyle will.??  

The CXOs further added that North America serves as the potential market for due to heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. Asia-Pacific is expected to exhibit fastest market growth due to increase in diabetic population and rise in prevalence of heart attack. In addition, pharmaceutical companies have focused on expanding their presence in emerging economies, which is anticipated to drive the market growth.?